SUMMARY Forty-two patients with frozen shoulder were followed up closely for eight months. They were all taught pendular exercises and randomly allocated to one of four treatment groups: (a) intraarticular steroids, (b) mobilisations, (c) ice therapy, (d) no treatment. This study has shown that there is little long-term advantage in any of the treatment regimens but that steroid injections may benefit pain and range of movement in the early stages of the condition.
Frozen shoulder is a rheumatological enigma. Precise definition varies, response to the many recommended treatments is often capricious, and many of the published reports are difficult to interpret because they are based on small series or Twenty-two involved the dominant arm and only one became bilateral. The onset was spontaneous in 27 cases and followed minor trauma in 14 patients. Twelve of the patients were manual workers, but this did not influence the arm involved. Although the frozen shoulder followed a herpes zoster infection of the T8 dermatone in one patient, no other known precipitating factors such as strokes, myocardial infarctions, or diabetes mellitus were present.
The age range was 44-74 years (mean 55.8), and the duration of the condition at presentation was 1-12 months (mean 4.8). Fig. 1 shows the distribution of age, sex, and disease duration before treatment.
Clinical assessment was performed before treatment, weekly for 6 weeks and monthly for a further 6 months by an independent observer who was not aware of the treatment given.
Pain scores were recorded on 10 cm visual analogue scales for night pain, pain on movement, and rest pain during the day. Patients The patients were randomly allocated to one of four treatment groups.
(1) Steroid group (11 patients). Methyl prednisolone acetate 20 mg and 1% lignocaine hydrochloride 0-5 ml were injected into the subacromial bursa and a similar amount into the shoulder joint by the anterior route, weekly, for three weeks.
(2) Mobilisation group (11 patients). Maitland's mobilisations17 were given by a research physiotherapist to these patients, three times weekly for six weeks.
(3) Ice group (12 patients). Ice packs followed by proprioceptive neuromuscular facilitation (PNF) was supervised by the same research physiotherapist with a similar time schedule to the mobilisation group.
(4) Non-treatment group (8 patients affecting half the patients, but was equally distributed in the other groups. All types of pain were still experienced-rest pain, night pain, and pain on movement. The maximum improvement in pain was achieved by the fourth week of treatment and then continued slowly after that. This was most obvious in the steroid group, but did not reach statistical significance.
SHOULDER MEASUREMENT
Recovery curves were plotted for each movement showing the average improvement in degrees between consecutive visits in each treatment group against time (Figs. 4-7 ). These were further analysed by the method described by Lee et The component C was calculated for each patient at each time, and the cumulative effect was plotted as for the individual measurements. It can be seen that a low value for C represented a poor range of movement and a higher value an improvement. Thus we were able to draw a cumulative recovery curve (Fig. 8) . Figs. [4] [5] [6] [7] Recovery curves showing average improvement in degrees between consecutive visits for total flexion (Fig. 4) , total abduction (Fig. 5 ), external rotation (Fig. 6) , and total rotation (Fig. 7) . Steroid Nobilisation Ice Placebo (Figs. 4-8 rate of recovery of shoulder movement whether the dominant or the non-dominant shoulder was affected. Similarly, presentation before or after three months had no statistically significant effect on the recovery of shoulder movement at six weeks and at the end of the study, although from the graph (Fig. 9) it appears that the early presentation group had a better initial response. There was also no relationship between the principal component at the start of the study and at the end. Thus the initial severity of restriction gave no indication of the final outcome as far as range was concerned.
CONTROL MEASUREMENTS
The range of shoulder movement in our controls was compared for right and left shoulders and for dominant and non-dominant shoulders by Student's t test (Table 1 ). No significant difference was found (p<005), but rotation and particularly flexion were better on the left or non-dominant shoulder and abduction was better on the right or dominant shoulder. Only 12 controls were left dominant, so that the above comparisons could be expected to
give very similar results.
Using the right shoulder of the 76 controls and ignoring age, we compared the range of movement between males and females and found a significantly greater range in females, for total abduction (p<002) total rotation (p<0-02) and external rotation (p<0-001) (unpaired t test with 48 DF). Total flexion was not significantly different between the sexes. Performing a linear regression against age gave significant decreases (p<0.001) in the range of all movements except external rotation. External rotation seemed to be poor in the youngest patients, under 50 years old. In view of the above findings a comparison between the same four measurements in our patients at 6 months after treatment was made Hazleman,10 and later Oldham,'2 have suggested that early presentation is associated with a shorter total duration. The patients whom we saw early tended to improve rapidly, but this was not sustained, and there did not appear to be any long-term benefit (Fig. 9) .
We have found less benefit from physiotherapy compared with non-treatment than Lee et al, " but they used a slightly different patient group in that 16/25 patients had had a frozen shoulder for more than one year, some for five years or more. Their placebo group was measured after six weeks, while the active treatment groups were measured weekly.
We saw all our patients weekly and gave them similar encouragement in order to minimise differences between them.
We found the method of measurement recommended by Clarke This study has shown that there is little long-term advantage in any of our treatment regimens over no treatment, but that steroid injections may benefit pain and range of movement in the early stages. There appears to be little place for physiotherapy alone, and, if used, it should not be continued for more than four weeks.
Significant range restriction, often unrecognised by the patient, was confirmed in most of our patients six months after treatment. Further follow-up was therefore undertaken to determine the long-term outcome.
We thank the Arthritis and Rheumatism Council for support.
